# High-Dose Phospholipid Omega-3 (EPA/DHA) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Physiologically, both EPA and DHA act as critical competitive substrates for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. By outcompeting pro-inflammatory arachidonic acid (an Omega-6) for these enzymes, they drastically downregulate the systemic production of inflammatory eicosanoids (prostaglandins and leukotrienes)17. Crucially, they serve as the direct biological precursors for a highly specialized class of immune-resolving autacoids known as Specialized Pro-resolving Mediators (SPMs)—which include resolvins, protectins, and maresins17. Unlike traditional anti-inflammatory pharmaceutical drugs (like NSAIDs) that merely block the initiation pathways of inflammation, SPMs actively orchestrate the actual resolution phase of the inflammatory response17. They achieve this by directly stimulating macrophage phagocytosis to clear out cellular debris, severely lowering serum triglyceride concentrations in the liver, reducing all-cause cardiovascular mortality risk by upwards of 21 percent, and restoring total tissue homeostasis following acute metabolic, physical, or immune stress17.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **90/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 90/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 84/100 (Higher is safer)
- **Time Burden**: ~15 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 3/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Physiologically, both EPA and DHA act as critical competitive substrates for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. By outcompeting pro-inflammatory arachidonic acid (an Omega-6) for these enzymes, they drastically downregulate the systemic production of inflammatory eicosanoids (prostaglandins and leukotrienes)17. Crucially, they serve as the direct biological precursors for a highly specialized class of immune-resolving autacoids known as Specialized Pro-resolving Mediators (SPMs)—which include resolvins, protectins, and maresins17. Unlike traditional anti-inflammatory pharmaceutical drugs (like NSAIDs) that merely block the initiation pathways of inflammation, SPMs actively orchestrate the actual resolution phase of the inflammatory response17. They achieve this by directly stimulating macrophage phagocytosis to clear out cellular debris, severely lowering serum triglyceride concentrations in the liver, reducing all-cause cardiovascular mortality risk by upwards of 21 percent, and restoring total tissue homeostasis following acute metabolic, physical, or immune stress17.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **75/100** [Rank #48 of 133 in Heart] - Effect: Supports arterial compliance and vascular tone
    - Mechanism: Promotes microvascular nitric oxide bioavailability and reduces lipid peroxidation.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 3,000-4,000mg EPA/DHA (taken with fatty meal)
- **Recommended Timing**: Morning Meal (09:00 AM)
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: focus, energy, skin_clarity, heart_health

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: None reported in standard human trials with recommended doses.
- **Safety Profile**: safe - Take with meal containing healthy fats for maximal intestinal absorption. Individuals taking prescription blood thinners should notify their physician.

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Cardiovascular Risk Reduction and Vascular Elasticity** [PMID: 30598199]
   - Link: https://pubmed.ncbi.nlm.nih.gov/30598199/
2. **Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia** [PMID: 30415628]
   - Link: https://pubmed.ncbi.nlm.nih.gov/30415628/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [High-Dose Phospholipid Omega-3 (EPA/DHA) on LongevityReviews](https://longevityreviews.org/modalities/rhonda_omega3_phospholipids)
- **Last Evidence Calibration**: 2026-08-08
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.